Swanton C - Search Results

1

Tracking Cancer Evolution through the Disease Course.

Bailey C, Black JRM, Reading JL, Litchfield K, Turajlic S, McGranahan N, Jamal-Hanjani M, Swanton C. Bailey C, et al. Among authors: swanton c. Cancer Discov. 2021 Apr;11(4):916-932. doi: 10.1158/2159-8290.CD-20-1559. Cancer Discov. 2021. PMID: 33811124 Free PMC article. Review.

2

A breast cancer meta-analysis of two expression measures of chromosomal instability reveals a relationship with younger age at diagnosis and high risk histopathological variables.

Endesfelder D, McGranahan N, Birkbak NJ, Szallasi Z, Kschischo M, Graham TA, Swanton C. Endesfelder D, et al. Among authors: swanton c. Oncotarget. 2011 Jul;2(7):529-37. doi: 10.18632/oncotarget.298. Oncotarget. 2011. PMID: 21709316 Free PMC article.

3

Cancer chromosomal instability: therapeutic and diagnostic challenges.

McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. McGranahan N, et al. Among authors: swanton c. EMBO Rep. 2012 Jun 1;13(6):528-38. doi: 10.1038/embor.2012.61. EMBO Rep. 2012. PMID: 22595889 Free PMC article. Review.

4

Intratumor heterogeneity: evolution through space and time.

Swanton C. Swanton C. Cancer Res. 2012 Oct 1;72(19):4875-82. doi: 10.1158/0008-5472.CAN-12-2217. Epub 2012 Sep 20. Cancer Res. 2012. PMID: 23002210 Free PMC article. Review.

5

Cancer heterogeneity: implications for targeted therapeutics.

Fisher R, Pusztai L, Swanton C. Fisher R, et al. Among authors: swanton c. Br J Cancer. 2013 Feb 19;108(3):479-85. doi: 10.1038/bjc.2012.581. Epub 2013 Jan 8. Br J Cancer. 2013. PMID: 23299535 Free PMC article. Review.

6

Taxane benefit in breast cancer--a role for grade and chromosomal stability.

A'Hern RP, Jamal-Hanjani M, Szász AM, Johnston SR, Reis-Filho JS, Roylance R, Swanton C. A'Hern RP, et al. Among authors: swanton c. Nat Rev Clin Oncol. 2013 Jun;10(6):357-64. doi: 10.1038/nrclinonc.2013.67. Epub 2013 May 7. Nat Rev Clin Oncol. 2013. PMID: 23648828 Review.

7

Tumour heterogeneity and immune-modulation.

Jamal-Hanjani M, Thanopoulou E, Peggs KS, Quezada SA, Swanton C. Jamal-Hanjani M, et al. Among authors: swanton c. Curr Opin Pharmacol. 2013 Aug;13(4):497-503. doi: 10.1016/j.coph.2013.04.006. Epub 2013 May 7. Curr Opin Pharmacol. 2013. PMID: 23664091 Free PMC article. Review.

8

Parallel evolution of tumour subclones mimics diversity between tumours.

Martinez P, Birkbak NJ, Gerlinger M, McGranahan N, Burrell RA, Rowan AJ, Joshi T, Fisher R, Larkin J, Szallasi Z, Swanton C. Martinez P, et al. Among authors: swanton c. J Pathol. 2013 Aug;230(4):356-64. doi: 10.1002/path.4214. J Pathol. 2013. PMID: 23716380

9

The causes and consequences of genetic heterogeneity in cancer evolution.

Burrell RA, McGranahan N, Bartek J, Swanton C. Burrell RA, et al. Among authors: swanton c. Nature. 2013 Sep 19;501(7467):338-45. doi: 10.1038/nature12625. Nature. 2013. PMID: 24048066 Review.

10

Implications of intratumour heterogeneity for treatment stratification.

Crockford A, Jamal-Hanjani M, Hicks J, Swanton C. Crockford A, et al. Among authors: swanton c. J Pathol. 2014 Jan;232(2):264-73. doi: 10.1002/path.4270. J Pathol. 2014. PMID: 24115146 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page